BiotechTube
Home/Eyconis/Mark Bachleda, PharmD, MBA
MB

Mark Bachleda, PharmD, MBA

Chief Executive Officer & Board Director

Eyconis

Therapeutic Areas

OphthalmologyRetinal Diseases

Eyconis Pipeline

DrugIndicationPhase
UndisclosedWet Age-Related Macular Degeneration (AMD), Diabetic Macular Edema (DME), Retinal Vein Occlusion (RVO), Geographic Atrophy (GA)Pre-clinical

Leadership Team at Eyconis

ET
Emmett T. Cunningham, Jr, MD, PhD, MPH
Co-Founder & Executive Chairman of the Board
OS
Oliver Stauch, PhD
Co-Founder & Chief Operating Officer
View full Eyconis profile